Rh2-enriched Korean ginseng (Ginseng Rh2+) inhibits tumor growth and development of metastasis of non-small cell lung cancer
Copyright policy )Rh2-enriched Korean ginseng (Ginseng Rh2+) inhibits tumor growth and development of metastasis of non-small cell lung cancer
While there are multiple studies on the anti-tumoral effects ofPanax ginsengas an active ingredient/s or as a whole plant extract, there is a lack of studies to assess the effect ofPanax ginsengactive ingredients combined with the whole plant extract.
- Tel Aviv University Israel
- Sangji University Korea (Republic of)
- Daejeon University Korea (Republic of)
- Tel Aviv Sourasky Medical Center Israel
- Dunsan Korean Medicine Hospital Korea (Republic of)
Lung Neoplasms, Ginsenosides, Plant Extracts, Panax, Antineoplastic Agents, Apoptosis, Mice, Proto-Oncogene Proteins c-bcl-2, Carcinoma, Non-Small-Cell Lung, Cell Line, Tumor, Animals, Humans, Neoplasm Metastasis, Cell Proliferation, bcl-2-Associated X Protein
Lung Neoplasms, Ginsenosides, Plant Extracts, Panax, Antineoplastic Agents, Apoptosis, Mice, Proto-Oncogene Proteins c-bcl-2, Carcinoma, Non-Small-Cell Lung, Cell Line, Tumor, Animals, Humans, Neoplasm Metastasis, Cell Proliferation, bcl-2-Associated X Protein
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).14 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!